Amikacin
2 results
Applied filters
Amikacin: informing intrathecal risk assessment
18 April 2026Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Implementing pharmacogenomic testing for aminoglycosides
9 January 2026Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.